What is NDC 63629-4306?

63629-4306 is the product NDC for Ondansetron, Ondansetron 8 mg/1 tablet, orally disintegrating, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 63629. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ondansetron?

190 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ondansetron NDC 63629-4306 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-4306Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-4306Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63629-4306-0	6362943060063629430600	3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-0)Marketed from Aug 20, 2010
63629-4306-1	6362943060163629430601	30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-1)Marketed from Aug 19, 2013
63629-4306-2	6362943060263629430602	10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-2)Marketed from Aug 19, 2013
63629-4306-3	6362943060363629430603	5 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-3)Marketed from Aug 19, 2013
63629-4306-4	6362943060463629430604	4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-4)Marketed from Aug 20, 2010
63629-4306-5	6362943060563629430605	6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-5)Marketed from Aug 20, 2010
63629-4306-6	6362943060663629430606	14 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-6)Marketed from Aug 20, 2010
63629-4306-7	6362943060763629430607	60 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-7)Marketed from Aug 20, 2010
63629-4306-8	6362943060863629430608	12 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-8)Marketed from Aug 20, 2010
63629-4306-9	6362943060963629430609	90 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (63629-4306-9)Marketed from Aug 20, 2010

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ondansetron
Generic name (nonproprietary): ondansetron
Active ingredients: Ondansetron — 8 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 63629
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077557
Marketing start: Aug 2, 2007
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 3 Receptor Antagonists (Mechanism)
Identifiers: Product ID 63629-4306_d33adc9e-77b0-4e55-90ab-0944938ccf1aSPL ID d33adc9e-77b0-4e55-90ab-0944938ccf1aSPL set ID 384a5cfb-05dd-2b79-73f4-a01a47a9eb3eRxCUI 198052, 312087UNII 4AF302ESOS
Pharmacologic class: Serotonin-3 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629430600 followed by a unit qualifier and the quantity

Package 63629-4306-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 2, 2025.

Indications (excerpt from the label)

Ondansetron is indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. Ondansetron is also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetronis a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . (1) na…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63629-4306

What is NDC 63629-4306?: 63629-4306 is the product NDC for Ondansetron, Ondansetron 8 mg/1 tablet, orally disintegrating, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ondansetron.
What is the active ingredient?: Ondansetron.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 63629. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ondansetron?: 190 other product NDCs are listed under this name. See all Ondansetron NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ondansetron NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	REMEDYREPACK INC.	70518-4685	70518-4685-00
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	Preferred Pharmaceuticals Inc.	68788-4133	68788-4133-0168788-4133-03
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-4882	00121-4882-94
Ondansetron	Ondansetron hydrochloride 4 mg/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-0882	00121-0882-51
Ondansetron	Ondansetron hydrochloride 2 mg/mL	InjectionIntramuscular, Intravenous	JVET PHARMACEUTICALS LLC	86211-115	86211-0115-01
Ondansetron	Ondansetron hydrochloride 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4588	70518-4588-00
Ondansetron	Ondansetron hydrochloride 2 mg/mL	Injection, SolutionIntramuscular, Intravenous	Hospira, Inc.	0409-2271	00409-2271-25
Ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	AvKARE	42291-457	42291-0457-30
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	AvKARE	42291-458	42291-0458-30
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	St. Mary's Medical Park Pharmacy	60760-936	60760-0936-10

All 191 Ondansetron NDCs

Other NDCs under ANDA 077557

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077557
Product	Strength	Form · route	Labeler	Product NDC
ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	Cardinal Health 107, LLC	55154-4567
ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	Sun Pharmaceutical Industries, Inc.	62756-240
ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	Sun Pharmaceutical Industries, Inc.	62756-356
Ondansetron	Ondansetron 4 mg/1	Tablet, Orally disintegratingOral	Proficient Rx LP	63187-670
Ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	Proficient Rx LP	63187-693
ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	NuCare Pharmaceuticals,Inc.	68071-2284
ondansetron	Ondansetron 8 mg/1	Tablet, Orally disintegratingOral	NuCare Pharmaceuticals,Inc.	68071-5230